Treatment of stasis dermatitis using aminaphtone: a case series

INTRODUCTION: Stasis purpura is a common finding in clinical practice and is related to vascular alterations. CASE PRESENTATION: Four randomly-selected, Caucasian patients (a 45-year-old woman, a 26-year-old man, a 51-year-old man and a 56-year-old woman) were treated with aminaphtone for approximat...

Descripción completa

Detalles Bibliográficos
Autor principal: de Godoy, José Maria Pereira
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940795/
https://www.ncbi.nlm.nih.gov/pubmed/20807403
http://dx.doi.org/10.1186/1752-1947-4-295
_version_ 1782186844336685056
author de Godoy, José Maria Pereira
author_facet de Godoy, José Maria Pereira
author_sort de Godoy, José Maria Pereira
collection PubMed
description INTRODUCTION: Stasis purpura is a common finding in clinical practice and is related to vascular alterations. CASE PRESENTATION: Four randomly-selected, Caucasian patients (a 45-year-old woman, a 26-year-old man, a 51-year-old man and a 56-year-old woman) were treated with aminaphtone for approximately one year. For all patients, the brown patches - a sign of stasis purpura - disappeared without the appearance of new lesions within this period. CONCLUSION: Aminaphtone is a novel proposal in the treatment of stasis purpura when capillary fragility is identified.
format Text
id pubmed-2940795
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29407952010-09-17 Treatment of stasis dermatitis using aminaphtone: a case series de Godoy, José Maria Pereira J Med Case Reports Case Report INTRODUCTION: Stasis purpura is a common finding in clinical practice and is related to vascular alterations. CASE PRESENTATION: Four randomly-selected, Caucasian patients (a 45-year-old woman, a 26-year-old man, a 51-year-old man and a 56-year-old woman) were treated with aminaphtone for approximately one year. For all patients, the brown patches - a sign of stasis purpura - disappeared without the appearance of new lesions within this period. CONCLUSION: Aminaphtone is a novel proposal in the treatment of stasis purpura when capillary fragility is identified. BioMed Central 2010-08-31 /pmc/articles/PMC2940795/ /pubmed/20807403 http://dx.doi.org/10.1186/1752-1947-4-295 Text en Copyright ©2010 de Godoy; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
de Godoy, José Maria Pereira
Treatment of stasis dermatitis using aminaphtone: a case series
title Treatment of stasis dermatitis using aminaphtone: a case series
title_full Treatment of stasis dermatitis using aminaphtone: a case series
title_fullStr Treatment of stasis dermatitis using aminaphtone: a case series
title_full_unstemmed Treatment of stasis dermatitis using aminaphtone: a case series
title_short Treatment of stasis dermatitis using aminaphtone: a case series
title_sort treatment of stasis dermatitis using aminaphtone: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940795/
https://www.ncbi.nlm.nih.gov/pubmed/20807403
http://dx.doi.org/10.1186/1752-1947-4-295
work_keys_str_mv AT degodoyjosemariapereira treatmentofstasisdermatitisusingaminaphtoneacaseseries

Ejemplares similares